Antimicrobial Agents and Chemotherapy · 2001 · 82 citations · 16 references
Life SciencesInfectious DiseasesMolecular BiologyMolecular VirologyVirologyAntiviral PharmacologyAntiviral PharmacotherapyAntiviral TherapyViral InfectionsHerpes Simplex Virus LatencyHerpes Simplex Virus ReactivationHerpesvirus Reactivation
Herpes simplex virus (HSV) reactivation from latency was investigated. Reactivation of thymidine kinase-negative HSV, which is defective for reactivation, was greatly enhanced by thymidine (TdR). The reactivation-enhancing effect of TdR was blocked by dipyridamole (DPM), a known nucleoside transport inhibitor. DPM also inhibited wild-type HSV reactivation, suggesting potential antiviral use.
16
Donald M. Coen, Magdalena Kosz‐Vnenchak, Jennie G. Jacobson et al. · Proceedings of the National Academy of Sciences · 1989 · 361 citations · Full text
The Role of Herpes Simplex Virus Type 1 Thymidine Kinase in Pathogenesis
Stacey Efstathiou, Sharon D. Kemp, G. Darby et al. · Journal of General Virology · 1989 · 229 citations